Silymarin 420 mg

DRUG2 trials

Sponsors

Madaus Inc, Liaquat National Hospital & Medical College

Conditions

Drug Induced Liver InjuryNon-alcoholic SteatohepatitisTuberculosis (TB)

Phase 1

Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi

Not yet recruitingNCT07058090

Liaquat National Hospital & Medical CollegeDrug Induced Liver Injury, Tuberculosis (TB)

Start: 2025-07-31End: 2026-05-31Target: 410Updated: 2025-07-10

Phase 2

Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis

CompletedNCT00680407

Madaus IncNon-alcoholic Steatohepatitis

Start: 2008-04-30End: 2012-11-30Updated: 2019-07-17

Related Papers

Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial

PLoS ONE2019-09-19117 citations